A validation study to investigate the role of Central Hypertension in Atrial Fibrillation Outcome
Not Applicable
Completed
- Conditions
- Atrial FibrillationCardiovascular - HypertensionHypertensionCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12616001225404
- Lead Sponsor
- CHRD, Royal Adelaide Hospital,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients undergoing AF ablation for symptomatic PAF
Age range 18-80 yrs
Exclusion Criteria
1. Patients contraindicated for exercise testing according to American Heart
Association (AHA) guidelines.
2. Acute decompensated heart failure
3. Unstable angina or recent MI (less than 4 weeks)
4. Hemodynamic instability
5. Connective tissue disorders involving aortic root.
6. Moderate to severe aortic valve insufficiency
7. Advanced valvular heart disease
8. Constrictive or restrictive cardiomyopathy
9. Pregnancy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method